BioSNTR is committed to building partnerships between academia and industry. Working alongside SD Bio, we identify mutual research interests and encourage discussion through individual meetings, facility tours, and networking events.


Industry Liaisons

SD BioTech Research Park at South Dakota State University University of South Dakota Discovery District


SAb Biotherapeutics Sponsored research for development of antigens for production of therapeutic antibodies 
Alumend, LLC. Sponsored research to develop photo-polymerizable stent technology
Bayer Crop Sciences Bayer Crop Science Collaborative Research Agreement 
Momenta Pharmaceuticals


Collaboration involving the control of immune cell function
Sanford Research Collaborative research with various faculty
Antimicrobial Materials, Inc. Service agreement to isolate and scale-up production of a yeast-produced antimicrobial peptide 
GlycoScience Research Inc. Sponsored research to develop a cGMP complaint method to isolate the GM1 ganglioside from bovine brain tissue.

 Sponsored research to develop new Assay technology

Secant Group, LLC

Secant is a Pennsylvania based biomaterials company who has executed an option to license US Patent "Biopolymer Drug Loading Method," developed with BioSNTR seed grant and invented by BioSNTR investigator Ying Deng.

Tailored Medical Devices Inc. Developed as a result of Phase 1 and Phase 2 of the BioSNTR Seed grants for drug-coated balloon technology SBIR application pending.


Colleges  |  Universities

South Dakota State University University of South Dakota South Dakota School of Mines and Technology
Augustana University Dakota Wesleyan University Black Hills State University
Northern State University Dakota State University Mount Marty College
Oglala Lakota College Sinte Gleska University Sisseton Wahpeton College

National/Academic Collaborations

South Dakota Programs & Offices


Industry looking for expert assistance in answering your research questions? Faculty with a commercial idea searching for private sector partners? Contact us for further discussion.